等待开盘 03-31 09:30:00 美东时间
-5.490
-3.14%
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
Here's a detailed look inside the Q4 earnings report from Dave.
03-03 06:47
华盛资讯3月3日讯,美国著名戴夫公布2025财年Q4业绩,公司Q4营收1.64亿美元,同比增长62.2%,归母净利润0.66亿美元,同比增长292.9%。
03-03 06:23
华盛资讯3月3日讯,美国著名戴夫公布2025财年年度业绩,公司年度营收5.54亿美元,同比增长59.7%,归母净利润1.96亿美元,同比增长238.5%。
03-03 05:48
Dave shares are trading higher after the company reported better-than-expected ...
03-03 05:18
Dave (NASDAQ:DAVE) is looking for FY2026 Adj EPS of $14.00-$15.00 vs $12.12 analyst estimate. sees sales of $690.000 million-$710.000 million vs $639.511 million analyst estimate.
03-03 05:14
Dave (NASDAQ:DAVE) reported quarterly earnings of $3.69 per share which beat the analyst consensus estimate of $3.19 by 15.6 percent. This is a 93.19 percent increase over earnings of $1.91 per share from the same period
03-03 05:11
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
华盛资讯2月6日讯,美国著名戴夫公布2025财年Q4业绩,公司Q4营收1.64亿美元,同比增长62.4%,归母净利润0.73亿美元,同比增长121.2%。
02-06 16:17